[Changes in expression level of TLR9 and BD-2 genes in cornea of mice with viral keratitis]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|March 27, 2012
PubMed
Abstract

Insights

Immunotherapy increased the expression of innate immunity genes, Toll-like receptor 9 (TLR9) and beta-defensin 2 (BD-2), in mouse corneas during viral keratitis. This suggests potential for treating ocular herpes.

Area of Science:

  • Ophthalmology
  • Immunology
  • Molecular Biology

Context:

  • Viral keratitis, a common ocular infection, involves complex immune responses in the cornea.
  • Innate immunity plays a crucial role in controlling viral infections, with specific genes like TLR9 and BD-2 being key players.

Purpose:

  • To investigate the expression of innate immunity genes (TLR9 and BD-2) in mouse corneal epithelial cells during viral keratitis.
  • To evaluate the effect of immunotherapy (Superlimf preparation) on the expression of these genes.

Summary:

  • Viral keratitis in C57B1/6 mice showed a significant decrease in Toll-like receptor 9 (TLR9) gene expression.
  • Treatment with Superlimf, a complex of cytokines and antimicrobial peptides, led to a statistically significant increase in TLR9 and beta-defensin 2 (BD-2) gene expression.

Impact:

  • The study establishes a model for viral keratitis and gene expression analysis to assess therapeutic interventions for ocular infections.
  • Findings support the potential use of immunotherapy in managing ophthalmic herpes by modulating innate immune responses.

Related Concept Videos